Isopentenyl Pyrophosphate-Activated CD56+ ???? T Lymphocytes Display Potent Antitumor Activity toward Human Squamous Cell Carcinoma, Clinical Cancer Research, vol.14, issue.13, pp.4232-4240, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-4912
???? T Cell Immune Manipulation during Chronic Phase of Simian HIV Infection Confers Immunological Benefits, The Journal of Immunology, vol.183, issue.8, pp.5407-5417, 2009. ,
DOI : 10.4049/jimmunol.0901760
Reduced Number and Impaired Function of Circulating ???? T Cells in Patients with Cutaneous Primary Melanoma, Journal of Investigative Dermatology, vol.120, issue.5, pp.829-834, 2003. ,
DOI : 10.1046/j.1523-1747.2003.12141.x
Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998. ,
DOI : 10.1038/32588
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA, Science, vol.285, issue.5428, pp.727-729, 1999. ,
DOI : 10.1126/science.285.5428.727
Phase-I study of Innacell ???????, an autologous cell-therapy product highly enriched in ??9??2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma, Cancer Immunology, Immunotherapy, vol.99, issue.11, pp.1599-1609, 2008. ,
DOI : 10.1007/s00262-008-0491-8
High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote V??9V??2 T-Cell Chemotaxis and Cytotoxicity In Vivo, Cancer Research, vol.71, issue.13, pp.4562-4572, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-3862
Regulatory T cells in cancer, Blood, vol.108, issue.3, pp.804-811, 2006. ,
DOI : 10.1182/blood-2006-02-002774
The function of ???? T cells in innate immunity, Current Opinion in Immunology, vol.18, issue.1, pp.31-38, 2006. ,
DOI : 10.1016/j.coi.2005.11.007
Professional Antigen-Presentation Function by Human gd T Cells, Science, vol.309, issue.5732, pp.264-268, 2005. ,
DOI : 10.1126/science.1110267
Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses, Proceedings of the National Academy of Sciences of the United States of America, pp.2307-2312, 2009. ,
DOI : 10.1073/pnas.0810059106
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650152
???? T Lymphocytes Count Is Normal and Expandable in Peripheral Blood of Patients with Follicular Lymphoma, Whereas It Is Decreased in Tumor Lymph Nodes Compared with Inflammatory Lymph Nodes, The Journal of Immunology, vol.184, issue.1, pp.134-140, 2010. ,
DOI : 10.4049/jimmunol.0901980
???? T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody, Haematologica, vol.96, issue.3, pp.400-407, 2011. ,
DOI : 10.3324/haematol.2010.029520
Comparative Analysis of Regulatory and Effector T Cells in Progressively Growing versus Rejecting Tumors of Similar Origins, Cancer Research, vol.66, issue.14, pp.7301-7309, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-0556
In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma, British Journal of Haematology, vol.83, issue.2, pp.206-216, 2007. ,
DOI : 10.1182/blood-2002-12-3665
URL : https://hal.archives-ouvertes.fr/inserm-00169215
Aminobisphosphonate-pretreated dendritic cells trigger successful V??9V??2 T cell amplification for immunotherapy in advanced cancer patients, Cancer Immunology, Immunotherapy, vol.157, issue.1, pp.1611-1619, 2010. ,
DOI : 10.1007/s00262-010-0887-0
Differentiation, phenotype, and function of interleukin-17-pro- ducing human Vgamma9Vdelta2 T cells, Blood, vol.118, pp.129-138, 2011. ,
Do human gammadelta T cells respond to M tuberculosis protein antigens? Blood, pp.4776-4777, 2008. ,
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between V??9V??2 T Cells, ???? CD8+ T Cells, Regulatory T Cells, and Dendritic Cells, The Journal of Immunology, vol.187, issue.4, pp.1578-1590, 2011. ,
DOI : 10.4049/jimmunol.1002514
A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct ???? and ???? T cell responses in primates, European Journal of Immunology, vol.278, issue.2, pp.549-565, 2007. ,
DOI : 10.1002/eji.200636343
Antigen recognition by ???? T cells, Immunological Reviews, vol.166, issue.1, pp.46-58, 2007. ,
DOI : 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y
Reciprocal Activating Interaction Between Dendritic Cells and Pamidronate-Stimulated ???? T Cells: Role of CD86 and Inflammatory Cytokines, The Journal of Immunology, vol.174, issue.1, pp.252-260, 2005. ,
DOI : 10.4049/jimmunol.174.1.252
V??9V??2 T Cell Response to Colon Carcinoma Cells, The Journal of Immunology, vol.175, issue.8, pp.5481-5488, 2005. ,
DOI : 10.4049/jimmunol.175.8.5481
V??9V??2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells, The Journal of Immunology, vol.184, issue.6, pp.3260-3268, 2010. ,
DOI : 10.4049/jimmunol.0903454
Potentiation of Antigen-Stimulated V??9V??2 T Cell Cytokine Production by Immature Dendritic Cells (DC) and Reciprocal Effect on DC Maturation, The Journal of Immunology, vol.176, issue.3, pp.1386-1393, 2006. ,
DOI : 10.4049/jimmunol.176.3.1386
Targeting Human ???? T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer, Cancer Research, vol.67, issue.15, pp.7450-7457, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-0199
IL-15 produced and trans-presented by DCs underlies homeostatic competition between CD8 and ???? T cells in vivo, Blood, vol.113, issue.25, pp.6361-6371, 2009. ,
DOI : 10.1182/blood-2008-12-192997
????-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-?? response to Plasmodium falciparum malaria, European Journal of Immunology, vol.159, issue.7, pp.1864-1873, 2007. ,
DOI : 10.1002/eji.200636889
Promiscuity and the single receptor: NKG2D, Nature Reviews Immunology, vol.201, issue.9, pp.737-744, 2007. ,
DOI : 10.1038/nri2144
) {gamma}{delta} T cell homeostasis is established in competition with {alpha}{beta} T cells and NK cells, Proceedings of the National Academy of Sciences of the United States of America, pp.14741-14746, 2005. ,
Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity, Expert Opinion on Therapeutic Targets, vol.2, issue.7, pp.941-954, 2007. ,
DOI : 10.1200/JCO.2003.02.122
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection, Journal of Clinical Oncology, vol.25, issue.18, pp.2586-2593, 2007. ,
DOI : 10.1200/JCO.2006.09.4565
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies, Blood, vol.113, issue.20, pp.4875-4884, 2009. ,
DOI : 10.1182/blood-2008-08-172296
Immunosurveillance and Immunoregulation by ???? T Cells, Journal of Investigative Dermatology, vol.126, issue.1, pp.25-31, 2006. ,
DOI : 10.1038/sj.jid.5700003
Human T Cell Receptor ???? Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells, The Journal of Experimental Medicine, vol.263, issue.2, pp.163-168, 2003. ,
DOI : 10.1038/sj.onc.1203002
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial T Cells, Science, vol.279, issue.5357, pp.1737-1740, 1998. ,
DOI : 10.1126/science.279.5357.1737
Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB, Proceedings of the National Academy of Sciences of the United States of America, pp.6879-6884, 1999. ,
The Participation of Mesenchymal Stem Cells in Tumor Stroma Formation and Their Application as Targeted-Gene Delivery Vehicles, Handbook of Experimental Pharmacology, vol.180, pp.263-283, 2007. ,
DOI : 10.1007/978-3-540-68976-8_12
Genetic Requirements for the Development and Differentiation of lnterleukin-17-Producing ???? T Cells, Critical Reviews??? in Immunology, vol.32, issue.1, pp.81-95, 2012. ,
DOI : 10.1615/CritRevImmunol.v32.i1.50
Type I IFN Signaling Constrains IL-17A/F Secretion by ???? T Cells during Bacterial Infections, The Journal of Immunology, vol.184, issue.7, pp.3755-3767 ,
DOI : 10.4049/jimmunol.0902065
Human ???? T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells, The Journal of Immunology, vol.188, issue.4, pp.1708-1716, 2012. ,
DOI : 10.4049/jimmunol.1102654
Control of Regulatory T Cell Development by the Transcription Factor Foxp3, Science, vol.299, issue.5609, pp.1057-1061, 2003. ,
DOI : 10.1126/science.1079490
Immunotherapy targeting colon cancer stem cells, Immunotherapy, vol.3, issue.1, pp.97-106, 2011. ,
DOI : 10.2217/imt.10.87
An integrated view of suppressor T cell subsets in immunoregulation, Journal of Clinical Investigation, vol.114, issue.9, pp.1198-1208, 2004. ,
DOI : 10.1172/JCI23411
Adoptive immunotherapy of lung cancer with immobilized anti-TCR???? antibody-expanded human ???? T Cells in peripheral blood, Cancer Biology & Therapy, vol.8, issue.16, pp.1540-1549, 2009. ,
DOI : 10.4161/cbt.8.16.8950
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, vol.9, issue.7162, pp.557-563, 2007. ,
DOI : 10.1038/nature06188
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study, Cancer Immunology, Immunotherapy, vol.173, issue.11, pp.469-476, 2007. ,
DOI : 10.1007/s00262-006-0199-6
Phase I/II study of adoptive transfer of ???? T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma, Cancer Immunology, Immunotherapy, vol.30, issue.Suppl 1, pp.1075-1084, 2011. ,
DOI : 10.1007/s00262-011-1021-7
Zoledronate facilitates large-scale ex vivo expansion of functional ???? T cells from cancer patients for use in adoptive immunotherapy*, Cytotherapy, vol.10, issue.8, pp.842-856, 2008. ,
DOI : 10.1080/14653240802419328
???? T cells ??? innate immune lymphocytes?, Current Opinion in Immunology, vol.18, issue.5, pp.527-533, 2006. ,
DOI : 10.1016/j.coi.2006.07.008
Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma, Blood, vol.96, pp.384-392, 2000. ,
regulatory T cells, Immunology, vol.175, issue.2, pp.256-267, 2009. ,
DOI : 10.1111/j.1365-2567.2008.02894.x
Reduced Expression of the Mevalonate Pathway Enzyme Farnesyl Pyrophosphate Synthase Unveils Recognition of Tumor Cells by V??9V??2 T Cells, The Journal of Immunology, vol.182, issue.12, pp.8118-8124, 2009. ,
DOI : 10.4049/jimmunol.0900101
Coculture with dendritic cells promotes proliferation but not cytotoxic activity of ??/?? T cells, Immunology Letters, vol.99, issue.1, pp.103-108, 2005. ,
DOI : 10.1016/j.imlet.2005.02.001
EX VIVO EXPANDED HUMAN V??9V??2+ ????-T CELLS MEDIATE INNATE ANTITUMOR ACTIVITY AGAINST HUMAN PROSTATE CANCER CELLS IN VITRO, The Journal of Urology, vol.173, issue.5, pp.1552-1556, 2005. ,
DOI : 10.1097/01.ju.0000154355.45816.0b
Protective Immunosurveillance and Therapeutic Antitumor Activity of ???? T Cells Demonstrated in a Mouse Model of Prostate Cancer, The Journal of Immunology, vol.180, issue.9, pp.6044-6053, 2008. ,
DOI : 10.4049/jimmunol.180.9.6044
IL-17 Production Is Dominated by ???? T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection, The Journal of Immunology, vol.177, issue.7, pp.4662-4669, 2006. ,
DOI : 10.4049/jimmunol.177.7.4662
Contribution of IL-17???producing ???? T cells to the efficacy of anticancer chemotherapy, The Journal of Experimental Medicine, vol.178, issue.3, pp.491-503, 2011. ,
DOI : 10.1016/j.cell.2010.02.015
URL : https://hal.archives-ouvertes.fr/pasteur-00576679
Human ???? T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement, Blood, vol.116, issue.10, pp.1726-1733, 2010. ,
DOI : 10.1182/blood-2009-07-234211
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324253
Redirecting ????T cells against cancer cells by transfer of a broadly tumor-reactive ????T-cell receptor, Blood, vol.118, issue.1, pp.50-59, 2011. ,
DOI : 10.1182/blood-2010-12-325993
A regulatory cross-talk between V??9V??2 T lymphocytes and mesenchymal stem cells, European Journal of Immunology, vol.168, issue.3, pp.752-762, 2009. ,
DOI : 10.1002/eji.200838812
PGE2 inhibits natural killer and ???? T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling, Biochemical Pharmacology, vol.80, issue.6, pp.838-845, 2010. ,
DOI : 10.1016/j.bcp.2010.05.002
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients, Clinical and Experimental Immunology, vol.161, pp.290-297, 2010. ,
Prolonged antigen survival and cytosolic export in cross-presenting human ???? T cells, Proceedings of the National Academy of Sciences, vol.107, issue.19, pp.8730-8735, 2010. ,
DOI : 10.1073/pnas.1002769107
???? T cells: novel initiators of adaptive immunity, Immunological Reviews, vol.172, issue.1, pp.89-102, 2007. ,
DOI : 10.1016/j.immuni.2006.06.002
Zoledronate-activated V??9???? T cell-based immunotherapy is feasible and restores the impairment of ???? T cells in patients with solid tumors, Cytotherapy, vol.13, issue.1, pp.92-97, 2011. ,
DOI : 10.3109/14653249.2010.515581
DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by ???? T lymphocytes, Blood, vol.118, issue.10, pp.2743-2751, 2011. ,
DOI : 10.1182/blood-2011-01-328526
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity, Cancer Research, vol.62, pp.6178-6186, 2002. ,
Reciprocal Interactions Between Human Mesenchymal Stem Cells and ???? T Cells Or Invariant Natural Killer T Cells, Stem Cells, vol.9, issue.3, pp.693-702, 2009. ,
DOI : 10.1634/stemcells.2008-0687
Type 1 Responses of Human V??9V??2 T Cells to Influenza A Viruses, Journal of Virology, vol.85, issue.19, pp.10109-10116, 2011. ,
DOI : 10.1128/JVI.05341-11
CD27 is a thymic determinant of the balance between interferon-??- and interleukin 17???producing ???? T cell subsets, Nature Immunology, vol.170, issue.4, pp.427-436, 2009. ,
DOI : 10.1038/ni.1717
Cutting Edge: Adaptive Versus Innate Receptor Signals Selectively Control the Pool Sizes of Murine IFN-??- or IL-17-Producing ???? T Cells upon Infection, The Journal of Immunology, vol.185, issue.11, pp.6421-6425, 2010. ,
DOI : 10.4049/jimmunol.1002283
Peripheral blood monocytes are responsible for ???? T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP, British Journal of Haematology, vol.69, issue.2, pp.245-250, 2009. ,
DOI : 10.1111/j.1365-2141.2008.07435.x
Interferon-?? does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, Clinical & Experimental Immunology, vol.326, issue.2, pp.353-363, 2007. ,
DOI : 10.1111/j.1365-2249.2007.03422.x
Anti-tumor cytotoxicity of ???? T cells expanded from peripheral blood cells of patients with myeloma and lymphoma, Medical Oncology, vol.328, issue.2, pp.137-147, 2008. ,
DOI : 10.1007/s12032-007-9004-4
Large scale expansion of ??9??2 T lymphocytes: Innacell ??????? cell therapy product, Journal of Immunological Methods, vol.326, issue.1-2, pp.63-75, 2007. ,
DOI : 10.1016/j.jim.2007.07.010
Tumor Recognition following V??9V??2 T Cell Receptor Interactions with a Surface F1-ATPase-Related Structure and Apolipoprotein A-I, Immunity, vol.22, issue.1, pp.71-80, 2005. ,
DOI : 10.1016/j.immuni.2004.11.012
Reduced Immune Response to Borrelia burgdorferi in the Absence of ???? T Cells, Infection and Immunity, vol.79, issue.10, pp.3940-3946, 2011. ,
DOI : 10.1128/IAI.00148-11
In Vivo Immunomanipulation of V??9V??2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model, The Journal of Immunology, vol.175, issue.8, pp.5471-5480, 2005. ,
DOI : 10.4049/jimmunol.175.8.5471
Design, Synthesis, and Biological Evaluation of Novel Aminobisphosphonates Possessing an in Vivo Antitumor Activity Through a ????-T Lymphocytes-Mediated Activation Mechanism, Journal of Medicinal Chemistry, vol.51, issue.21, pp.6800-6807, 2008. ,
DOI : 10.1021/jm801003y
Only a Subset of Phosphoantigen-Responsive ??9??2 T Cells Mediate Protective Tuberculosis Immunity, The Journal of Immunology, vol.181, issue.7, pp.4471-4484, 2008. ,
DOI : 10.4049/jimmunol.181.7.4471
Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity, Immunity, pp.31-331, 2009. ,
IL-17 production by ???? T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Gu??rin treatment against bladder cancer, European Journal of Immunology, vol.59, issue.1, pp.246-251, 2011. ,
DOI : 10.1002/eji.201040773
Self/non-self discrimination by human ???? T cells: simple solutions for a complex issue?, Immunological Reviews, vol.153, issue.1, pp.123-135, 2007. ,
DOI : 10.1182/blood-2004-01-0331
IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human V??9V??2 T Cells for Adoptive Immunotherapy, The Journal of Immunology, vol.182, issue.6, pp.3423-3431, 2009. ,
DOI : 10.4049/jimmunol.0803068
Alkylamines cause V??9V??2 T-cell activation and proliferation by inhibiting the mevalonate pathway, Blood, vol.107, issue.2, pp.651-654, 2006. ,
DOI : 10.1182/blood-2005-03-1025
V??9V??2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs???Rituximab and trastuzumab, International Journal of Cancer, vol.67, issue.11, pp.2526-2534, 2008. ,
DOI : 10.1002/ijc.23365
Phosphostim-Activated ???? T Cells Kill Autologous Metastatic Renal Cell Carcinoma, The Journal of Immunology, vol.174, issue.3, pp.1338-1347, 2005. ,
DOI : 10.4049/jimmunol.174.3.1338
Chemokine Receptors Expression and Migration Potential of Tumor-infiltrating and Peripheral-expanded V??9V??2 T Cells From Renal Cell Carcinoma Patients, Journal of Immunotherapy, vol.31, issue.3, pp.313-323, 2008. ,
DOI : 10.1097/CJI.0b013e3181609988
Innate or Adaptive Immunity? The Example of Natural Killer Cells, Science, vol.331, issue.6013, pp.44-49, 2011. ,
DOI : 10.1126/science.1198687
URL : https://hal.archives-ouvertes.fr/hal-00611585
???? T cells for immune therapy of patients with lymphoid malignancies, Blood, vol.102, issue.1, pp.200-206, 2003. ,
DOI : 10.1182/blood-2002-12-3665
Human NK Cells Positively Regulate ???? T Cells in Response to Mycobacterium tuberculosis, The Journal of Immunology, vol.176, issue.4, pp.2610-2616, 2006. ,
DOI : 10.4049/jimmunol.176.4.2610
Peripheral ?? T-cell deficit in nasopharyngeal carcinoma, International Journal of Cancer, vol.294, issue.2, pp.213-217, 2002. ,
DOI : 10.1002/ijc.10326